Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis.

AIDS reviews - 1 Jan 2023

Kandeel Mahmoud

Abstract excerpt

HIV is a global deliberating infectious disease. Of note, more than 36 million people living with HIV (PLHIV) with approximately newly diagnosed 1.5 million cases annually. M184V is a single base mutation in the highly conserved YMDD domain of reverse transcriptase (RT). It is one of the most encountered resistances associated with mutations to nucleoside RT inhibitors. There were continuous efforts to evaluate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to Mutation

Share to Reverse Transcriptase Inhibitors

Share to Treatment Outcome

Source

Identifiers

PMID: 37879631
DOI: 10.24875/AIDSRev.23000002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis.PMID 37879631Read ↗

Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V MutationSemantic proximity Read ↗

Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation.Semantic proximity Read ↗

The M184V mutation: what it does, how to prevent it, and what to do with it when it's there.Semantic proximity Read ↗

2017 Update of the Drug Resistance Mutations in HIV-1.Semantic proximity Read ↗

2015 Update of the Drug Resistance Mutations in HIV-1.Semantic proximity Read ↗

The multiple benefits associated with HIV drug-resistance mutation M184V.Semantic proximity Read ↗

Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.Semantic proximity Read ↗

Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort StudySemantic proximity Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

Virologic status and pattern of drug resistance mutation among ART-experienced HIV-infected patients in Butuo County, China.Semantic proximity Read ↗

Update of the drug resistance mutations in HIV-1: March 2013.Semantic proximity Read ↗

[Drug resistance mutations and its associated factors among 579 HIV/AIDS patients experiencing failure of antiretroviral therapy in Jiangsu Province, China].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.